Plunkett's Biotech & Genetics Industry Almanac 2006: The Only Complete Reference to the Business of Biotechnology and Genetic Engineering

Plunkett's Biotech & Genetics Industry Almanac 2006: The Only Complete Reference to the Business of Biotechnology and Genetic Engineering

Author: Plunkett Research, Ltd

Publisher: Plunkett Research, Ltd.

Published: 2005

Total Pages: 584

ISBN-13: 1593920334

DOWNLOAD EBOOK

A complete guide to the business of biotech, genetics, proteomics and related services. Complete profiles of nearly 450 leading biotech companies, in-depth chapters on trends. Includes glossary thorough indexes, statistics, research and development, emerging technology.


EDURANT Drug Profile, 2023

EDURANT Drug Profile, 2023

Author: DrugPatentWatch

Publisher: DrugPatentWatch.com

Published: 2023-08-15

Total Pages: 100

ISBN-13: 1934899860

DOWNLOAD EBOOK

EDURANT Drug Profile, 2023

This report focuses on EDURANT and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • District Court patent litigation
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources


The Venture Alchemists

The Venture Alchemists

Author: Rob Lalka

Publisher: Columbia University Press

Published: 2024-05-14

Total Pages: 324

ISBN-13: 0231558333

DOWNLOAD EBOOK

We once idolized tech entrepreneurs for creating innovations that seemed like modern miracles. Yet our faith has been shattered. We now blame them for spreading lies, breaking laws, and causing chaos. Yesterday’s Silicon Valley darlings have become today’s Big Tech villains. Which is it? Are they superheroes or scoundrels? Or is it more complicated, some blend of both? In The Venture Alchemists, Rob Lalka demystifies how tech entrepreneurs built empires that made trillions. Meta started as a cruel Halloween prank, Alphabet began as a master’s thesis that warned against corporate deception, and Palantir came from a campus controversy over hateful speech. These largely forgotten origin stories show how ordinary fears and youthful ambitions shaped their ventures—making each tech tale relatable, both wonderfully and tragically human. Readers learn about the adversities tech entrepreneurs overcame, the troubling tradeoffs they made, and the tremendous power they now wield. Using leaked documents and previously unpublished archival material, Lalka takes readers inside Big Tech’s worst exploitations and abuses, alongside many good intentions and moral compromises. But this story remains unfinished, and The Venture Alchemists ultimately offers hope from the people who, decades ago, warned about the risks of the emerging Internet. Their insights illuminate a path toward more responsible innovations, so that technologies aren’t dangerous weapons but valuable tools that ensure progress, improve society, and enhance our daily lives.